Needle-free Injectors Market (By Product: Fillable, Prefilled; By Technology; By Type; By Application; By Usability; By Delivery Site; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global needle-free Injectors market was valued at USD 124.2 million in 2021 and it is predicted to surpass around USD 276.3 million by 2030 with a CAGR of 9.29% from 2022 to 2030.

Needle-free Injectors Market Size 2021 to 2030

An increasing number of infectious diseases across the globe is escalating the demand for self-injection devices, and the rising need for vaccination is the major factor projected to fuel the market growth. An increase in the geriatric population base developing communicable diseases due to needle stick injuries is estimated to surge the demand for needle-free Injectors over the forecast period. Additionally, the rising focus of market players on developing safe, pain-free, and advanced injectors is expected to augment the market expansion.

Recent advancements and product approvals as well as upgradation in needle-free injectors are anticipated to contribute towards market growth. In August 2022, WHO nominated the PharmaJet Tropis needle-free Injection System for huge polio vaccination campaigns. In July 2022, NuGen Medical Devices Inc. announced that its InsuJet has been approved and accepted by Health Canada explicitly for the needle-free delivery of insulin.

Injections are one of the most common medical devices used for drug administration. Due to this, healthcare professionals are at great risk of exposure to bloodborne pathogens owing to needle stick injuries, which can occur accidentally. According to Occupational Safety and Health Administration (OSHA), around 590,000 needle stick accidents occur each year.

Asia Pacific region is estimated to exhibit the highest CAGR during the forecast period owing to increasing investments in the region by key market players, and rapid development of the healthcare industry in countries such as India, China, Japan, and others. Availability of low-cost labor for manufacturing, growing demand for self-injection devices, and the presence of favorable regulatory scenarios are major factors anticipated to create wide growth opportunities for current and upcoming market players.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 124.2 million
Revenue Forecast by 2030 USD 276.3 million 
Growth rate from 2022 to 2030 CAGR of 9.29%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Product, Technology, Type, Application, Usability, Delivery Site, End-use, Region
Companies Covered

PharmaJet, Crossject, Portal Instruments, NuGen Medical Devices, Inovio Pharmaceuticals, Antares Pharma, Inc, Aijex Pharma International Inc., Ferring B.V., Penjet Corporation, and Medical International Technology Inc.


Key Players

  • PharmaJet
  • Crossject
  • Portal Instruments
  • NuGen Medical Devices
  • Inovio Pharmaceuticals
  • Antares Pharma, Inc
  • Aijex Pharma International Inc.
  • Ferring B.V.
  • Penjet Corporation
  • Medical International Technology Inc.

Market Segmentation

  • By Product
    •  Fillable
    • Prefilled
  • By Technology
    • Spring-based needle-free Injectors
    • Gas-powered needle-free Injectors
    • Laser-powered needle-free Injectors
    • Vibration-based needle-free Injectors
  • By Type
    • Powder-based needle-free Injectors
    • Liquid-based needle-free Injectors
    • Projectile/depot-based needle-free Injectors
  • By Application
    • Vaccine Delivery
    • Insulin Delivery
    • Pain Management
    • Others
  • By Usability
    • Reusable
    • Disposable
  • By Delivery Site
    • Subcutaneous
    • Intramuscular
    • Intradermal
  • By End-use
    • Hospitals & Clinics
    • Home Care Settings
    • Research Laboratories
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Report Detail

Proceed To Buy

USD 3500
USD 7000